The Origin of the Synergistic Effect of Muramyl Dipeptide with Endotoxin and Peptidoglycan
Open Access
- 18 October 2002
- journal article
- Published by Elsevier BV
- Vol. 277 (42), 39179-39186
- https://doi.org/10.1074/jbc.m204885200
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- PEPTIDOGLYCAN PRIMES FOR LPS-INDUCED RELEASE OF PROINFLAMMATORY CYTOKINES IN WHOLE HUMAN BLOODShock, 2001
- Synergistic Effect of Muramyldipeptide with Lipopolysaccharide or Lipoteichoic Acid To Induce Inflammatory Cytokines in Human Monocytic Cells in CultureInfection and Immunity, 2001
- Chemokines Are the Main Proinflammatory Mediators in Human Monocytes Activated by Staphylococcus aureus, Peptidoglycan, and EndotoxinPublished by Elsevier BV ,2000
- Cellular Events Mediated by Lipopolysaccharide-stimulated Toll-like Receptor 4Published by Elsevier BV ,2000
- Synergistic Epithelial Responses to Endotoxin and a Naturally Occurring Muramyl PeptideInfection and Immunity, 2000
- Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich ElementsImmunity, 1999
- The Role of 3′ Poly(A) Tail Metabolism in Tumor Necrosis Factor-α RegulationJournal of Biological Chemistry, 1997
- Application of Transcriptional and Posttranscriptional Reporter Constructs to the Analysis of Tumor Necrosis Factor Gene RegulationThe American Journal of the Medical Sciences, 1992
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- A Three-Year Study of Positive Blood Cultures, with Emphasis on PrognosisClinical Infectious Diseases, 1990